Avacta, Integumen collaborate for detection of SARS-COV-2 in waste water
Avacta Group, the developer of Affimer biotherapeutics and reagents, has entered into a collaboration with Integumen to evaluate recently generated Affimer reagents that bind the SARS-COV-2 spike protein for the detection of the coronavirus in waste water, to provide a real-time alert system to warn of localised COVID-19 outbreaks. Over 60 percent of COVID-19 positive […]
